CIRC
CirTran Corp.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$0.22
−8.68%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -82.9%
- EBITDA
- +99.8%
- EPS
- +95.3%
Three-year CAGR
- Revenue
- +7081.2%
- EBITDA
- +60.8%
- EBIT
- —
- Net income
- +56.1%
- EPS
- +70.7%
- Free cash flow
- +26.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026